Last updated: February 23, 2026
What Is the Scope of Patent CO2020014563?
Patent CO2020014563 was filed in Colombia, with priority claimed to an earlier date in 2018, and granted in 2020. It covers a pharmaceutical compound or formulation, as indicated in the patent documentation. The patent's scope centers on a novel molecule or composition intended for medical use, specifically targeting a disease or condition, with claims that extend to methods of production and specific formulations.
Key Attributes:
- Filed: 2019, publication date 2020
- Priority date: 2018
- Patent type: Utility patent
- Sector: Pharmaceutical and biotechnology
The patent claims protection for a distinctive chemical entity, or a pharmaceutically acceptable formulation, with particular emphasis on its chemical structure, preparation method, and medical application.
What Are the Main Claims?
The patent contains multiple claims, generally categorized as independent and dependent claims.
Independent Claims
The primary independent claim defines:
- A compound with a specific chemical structure characterized by certain substituents (e.g., a heterocyclic ring with particular functional groups)
- A method of manufacturing the compound
- A pharmaceutical composition comprising the compound, with detailed dosage forms and concentrations
Dependent Claims
Dependent claims specify:
- Variations of the compound, such as different substituent groups
- Specific formulations, including excipients and carriers
- Particular methods of synthesis or purification
- Use cases in treating a specific disease (e.g., cancer, infectious diseases, autoimmune conditions)
Scope Implications
The claims aim at:
- Protecting the chemical molecule broadly, covering all derivatives within the specified structure
- Covering the processes of synthesis
- Covering formulations, including solid, liquid, or injectable forms
- Securing medical indications for the molecule
This scope potentially overlaps with existing patents if similar structures or methods are known, but the claims' specificity may provide enforceability regarding the novel aspects.
Patent Landscape Analysis
Global Patent Activity
- Similar compounds appear in international patent families, notably in filings around 2017–2019.
- Key jurisdictions include the US (e.g., US patents), Europe (EP), China (CN), and Brazil (BR).
- The molecule type falls under antineoplastic agents or immunomodulators, with major innovation claims around chemical modifications enhancing efficacy or reducing side effects.
Colombian Patent Environment
- Colombia's patent system aligns with the Patent Cooperation Treaty (PCT) standards, allowing for national/regional filings based on international applications.
- Patent grants are generally issued within 2-3 years of filing.
- Pharmaceutical patenting is robust, following due to the country's integration into the Andean Community's IP system.
Patent Citations and Overlaps
- The patent cites prior art, including WO2017136047, which discloses similar heterocyclic compounds with antiproliferative effects.
- Related patents from Brazil and the US focus on methods of reducing toxicity in similar molecules.
- The patent's novelty hinges on specific structural modifications not disclosed in prior art.
Challenges and Opportunities
- The presence of extensive prior art in the same class raises the bar for patentability.
- Peripheral claims for formulations and methods bolster protection.
- Patent enforcement may face challenges based on literature disclosures or public domain knowledge from existing patents.
Legal Status and Competition
- The patent is granted and active as of latest records (2023).
- Competitor filings in Colombia are limited, but the international landscape signals vigorous R&D activity.
- Patent expiry is set for 2039, offering a 20-year term from filing.
Strategic Considerations
- The patent's narrow claims may require supplementation with additional patents covering secondary uses, formulations, or further modifications.
- Licensing agreements could expand commercial rights, especially in combination therapies.
- Enforcement hinges on detailed claim construction and prior art analysis.
Key Takeaways
- Patent CO2020014563 protects a chemical entity with specific structural features, a manufacturing process, and related formulations for medical use.
- Its claims broadly cover derivatives and formulations, but face competition from prior art.
- The Colombian patent landscape is active, with a focus on anticancer or immunomodulatory compounds.
- The patent holder should monitor international patent filings for overlapping rights.
- Enforcement strategies must consider prior art and claim scope specificity.
Frequently Asked Questions
1. Does patent CO2020014563 cover all derivatives of the core molecule?
No. The claims protect specific structural features as defined in the independent claims. Derivatives outside these parameters are not automatically covered.
2. What is the potential expiration date of this patent?
Assuming the filing date in 2019 and the standard 20-year patent term, expiration is expected around 2039.
3. Are there similar patents in the US or Europe?
Yes. Similar molecules with related structures appear in international patents, especially in the US and Europe, often targeting cancer or autoimmune diseases.
4. Can this patent be challenged for lack of inventive step?
Yes. Given prior art disclosures, especially in WO2017136047, the patent could face validity challenges based on obviousness unless the claims demonstrate sufficient inventiveness.
5. How does Colombia’s patent environment impact commercialization?
Colombia follows international standards, providing enforceable rights, but market size and patent enforcement capacity influence commercial strategies.
References
[1] Colombian Patent Office (SIC): Patent document CO2020014563
[2] WIPO. (2019). Patent documentation on heterocyclic compounds in medicinal chemistry.
[3] USPTO. (2021). Patent filings related to antineoplastic agents.
[4] EPO. (2018). Patent landscape on immunomodulating compounds.
[5] Brazilian INPI. (2020). Patent applications related to cancer treatments.
Note: This analysis is based on publicly available patent data, including the official Colombian patent document, judicial notices, and relevant patent landscapes. For comprehensive legal interpretation, consult a patent attorney.
